Evidence map›Paper›PMID 30717724›Full record

ArticleBMC complementary and alternative medicine2019

Effects of Radix Linderae extracts on a mouse model of diabetic bladder dysfunction in later decompensated phase.

Xufeng Yang, Dawei Lian, Pinglong Fan, Yifei Xu, Jing Wang, Fangjun Chen, Huanling Lai, Weiwen Jiang, Linjie Zhang, Ping Huang and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Xufeng YangSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China.
Dawei LianSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China.
Pinglong FanSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China.
Yifei XuSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China.
Jing WangSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China.
Fangjun ChenSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China.
Huanling LaiSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China.
Weiwen JiangSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China.
Linjie ZhangSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China.
Ping HuangSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China. hping331@126.com.
Hongying CaoSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 51006, Guangdong, China. 1171629708@qq.com.
Guangzhou University of Chinese Medicine · CN

Funding

The National Natural Science Fund of China 81673676
6 · The paper itself

Abstract

backgroundThis study aimed to elucidate the effects and mechanisms of Radix Linderae (RL) extracts on a mouse model of diabetic bladder dysfunction (DBD), especially on later decompensated phase.

methodsMale C57BL/6J mice were intraperitoneally injected with streptozotocin (STZ) after 4 weeks of high-fat diet (HFD) feeding. DBD mouse models (later decompensated phase) were developed by 12-weeks persistent hyperglycemia and then treated with RL extracts for 4 weeks. During administration, the fasting blood glucose (FBG) test was performed once a week. Four weeks later, oral glucose tolerance test (OGTT), voided stain on paper (VSOP), and urodynamic alteration were explored. We also performed haematoxylin and eosin (H&E) and Masson's trichrome staining to observe the histology of the bladder. Then, the contractile responses to α, β-methylene ATP, capsaicin (CAP), KCl and carbachol were measured. Moreover, qPCR assay was performed to analyse the bladder gene expression levels of M

resultsThe diabetic mice exhibited higher FBG, OGTT and urine production, and no substantial alteration was observed after RL treatment. Urodynamic test showed the maximum bladder capacity (MBC), residual volume (RV) and bladder compliance (BC), as well as the decrement of voided efficiency (VE) and micturition volume (MV), remarkably increased in the DBD mice. Furthermore, RL treatment significant improved urodynamic urination, with lower MBC, RV, and, BC, as well as higher VE and MV, as compared with the model groups. The wall thickness of the bladder and the ratio of smooth muscle/collagen remarkably increased, and RL could effectively attenuate the pathological change. The response of bladder strips to the stimulus was also reduced in the DBD mice, and RL treatment markedly increased the contraction. Furthermore, the gene expression levels of M

conclusionsRL extracts can improve the bladder voiding functions of the DBD model mice in later decompensated phase, and underlying mechanisms was associated with mediating the gene expression of M

Indexed as

Drugs, Chinese HerbalAnimalsDiabetes Mellitus, ExperimentalDisease Models, AnimalLinderaMaleMiceMice, Inbred C57BLPlant RootsUrinary BladderUrinary Bladder DiseasesDrugs, Chinese HerbalDiabetic bladder dysfunctionHigh-fat dietLater decompensated phaseRadix LinderaeStreptozotocin

Identifiers

PMID30717724
PMCPMC6360732
OpenAlexW2944216243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.